Fahy Gurteen Laboratories is an Irish registered in vitro diagnostics company specializing in cancer biomarker identification/validation and IVD product development.
Fahy Gurteen's R&D pipeline includes biomarkers for cancer screening, diagnosis, staging, therapy selection and relapse monitoring. The company also offers development and reference laboratory services to global leaders in the field of cancer diagnostics.
Founded in Ireland in 2011, Fahy Gurteen has recently set up new R&D facilities at Cambridge Research Park, a premier site for scientific and technological innovation reflecting the research strengths at nearby Cambridge University.
Fahy Gurteen is now rapidly expanding its scientific core team to add to existing, extensive experience of IVD product development at senior management level.